International Biotechnology Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,702
| Closed | -$833K | – | 61 |
|
|
2019
Q2 | $833K | Hold |
11,702
| – | – | 0.31% | 55 |
|
|
2019
Q1 | $918K | Sell |
11,702
-78,547
| -87% | -$6.16M | 0.34% | 55 |
|
|
2018
Q4 | $6M | Buy |
90,249
+34,144
| +61% | +$2.27M | 3.72% | 10 |
|
|
2018
Q3 | $7.36M | Hold |
56,105
| – | – | 3.5% | 10 |
|
|
2018
Q2 | $7.25M | Sell |
56,105
-11,221
| -17% | -$1.45M | 2.78% | 14 |
|
|
2018
Q1 | $6.94M | Buy |
67,326
+20,839
| +45% | +$2.15M | 2.71% | 15 |
|
|
2017
Q4 | $3.97M | Hold |
46,487
| – | – | 1.4% | 24 |
|
|
2017
Q3 | $3.95M | Buy |
46,487
+32,060
| +222% | +$2.72M | 1.54% | 23 |
|
|
2017
Q2 | $1.09M | Hold |
14,427
| – | – | 0.42% | 48 |
|
|
2017
Q1 | $952K | Sell |
14,427
-33,663
| -70% | -$2.22M | 0.36% | 53 |
|
|
2016
Q4 | $3.05M | Buy |
+48,090
| New | +$3.05M | 1.37% | 19 |
|